NOVA MSC BERHAD 27 Feb 2020 [su_document url="http://www.nova-hub.com/wp-content/uploads/announcement/NMSC_3Qtr_report_FY1920-final.pdf"]
NOVA MSC BERHAD 26 Feb 2020 [su_document url="http://www.nova-hub.com/wp-content/uploads/announcement/Nova MSC Berhad - Abridged Prospectus.pdf"] [su_document url="http://www.nova-hub.com/wp-content/uploads/announcement/Nova MSC Berhad - NPA and RSF.pdf"]
NOVA MSC BERHAD 25 Feb 2020 We refer to the Company’s announcements made on 25 November 2019, 3 December 2019, 13 December 2019,
NOVA MSC BERHAD 13 Feb 2020 RENOUNCEABLE RIGHTS ISSUE OF UP TO 2,094,173,136 NEW IRREDEEMABLE CONVERTIBLE PREFERENCE SHARES ("RIGHTS ICPS") IN NOVA MSC
NOVA MSC BERHAD 13 Feb 2020 RENOUNCEABLE RIGHTS ISSUE OF UP TO 2,094,173,136 NEW IRREDEEMABLE CONVERTIBLE PREFERENCE SHARES ("RIGHTS ICPS") IN NOVA MSC
NOVA MSC BERHAD 13 Feb 2020 RENOUNCEABLE RIGHTS ISSUE OF UP TO 2,094,173,136 NEW IRREDEEMABLE CONVERTIBLE PREFERENCE SHARES ("RIGHTS ICPS") IN NOVA MSC
NOVA MSC BERHAD 12 Feb 2020 Entitlement subject Important Relevant Dates for Renounceable Rights Description RENOUNCEABLE RIGHTS ISSUE OF UP TO 2,094,173,136 NEW
NOVA MSC BERHAD 12 Feb 2020 Entitlement subject Rights Issue Type Renounceable Entitlement description RENOUNCEABLE RIGHTS ISSUE OF UP TO 2,094,173,136 NEW IRREDEEMABLE
Jan 2020 – In the article published by the The Ophthalmologist - Ophthalmic Frontiers: AI, four recognized artificial intelligence and deep learning gurus
Jan 2020 – EyRIS is pleased to announce that we have successfully undergone Phase 1 & 2 of EN ISO 13485:2016 audit by